Dave Warner, a medical neuroscientist with an MD/PhD from Loma Linda University, gained international recognition for pioneering new methods of physiologically based human-computer interaction. Dr. Warner's research efforts focused on advanced instrumentation and new methods of analysis applied to evaluating various aspects of human function as it relates to human-computer interaction. His research efforts identify methods and techniques that optimize information flow between conscious intelligent humans performing purposeful, complex, time critical, tasks and interactive computers systems using AI and deep learning. Dr. Warner's work has indicated an optimal mapping of interactive interface technologies to the human nervous system's capacity to transduce, assimilate, and respond intelligently to information in an integrative-multisensory interaction and will fundamentally change the way that humans interact with information systems. Application areas for this work include quantitative assessment of human performance, augmentative communication systems, environmental controls for the disabled, medical communications and integrated interactive educational systems. Dr. Warner is particularly active in technology transfer of aerospace and other defense derived technologies to the fields of health care and education. Specific areas of interest are: advanced instrumentation for the acquisition and analysis of medically relevant biological signals; intelligent informatic systems, which augment both the general flow of medical information and provide decision support for the health care professional; public accesses health information databases designed to empower the average citizen to become more involved in their own health care; and advanced training technologies that adaptively optimize interactive educational systems to the capacity of the user.
Over the past decade Dr. Warner's research efforts have expanded to focus on innovative uses of information and communication technologies to support civil/military interaction in disaster response and post conflict environments. Much of his recent work has been in military/civilian operations supporting cross-domain information sharing and open communications capabilities in very difficult settings such as refugee camps, disaster areas, and post conflict stability operations.
From 2006 to the present Dr. Warner has been directing an ongoing operational experimentation effort in eastern Afghanistan focused on demonstrating that incentivized information sharing is vital to complex operations. Environments conducive to information sharing benefits coalition partners, international organizations, non-governmental organizations (NGOs) along with the local community. Current efforts include exploring the use of open internet, social media and crowdsourcing as a force multiplier in civilian support to ongoing stability operations along the eastern border region of Afghanistan.
This panel will discuss successful university spinouts and commercializable research activities at three diverse university settings: Quadrant Biosciences at Upstate Medical University, Transonic Systems which initiated out of Cornell University and development of novel therapeutics at Albany Medical College. The panel is moderated by nationally recognized “entrepreneur in the business of helping entrepreneurs,” Dr. Thomas O’Neal who also serves as the Executive Director of the UCF Business Incubation Program where he has assisted in the formation of numerous companies and the commercialization of technologies developed at UCF.
Dr. O’Neal currently serves as the Associate Vice President of Research and Commercialization at UCF, Vice President of the UCF Research Foundation, Executive Director of the UCF Business Incubation Program (UCFBIP), Executive Director of the Florida Economic Gardening Institute (GrowFL), and the Executive Director of I-Corps at UCF, Florida’s first I-Corps site.
His pioneering work in business incubation and entrepreneurial ecosystems has helped build Central Florida’s innovation-based economy, which in turn has become an internationally-recognized model for economic development being used across the globe today.
Dr. O’Neal’s international recognition as an expert in research, engineering, technology transfer, business incubation, and economic development has led to presentations and instructional engagements on five continents. He has presented or taught at 18 international conferences, 35 national conferences, and 178 conferences throughout the State of Florida. His expertise has resulted in requests for consultations from government, academic and private industry leadership across international and national levels. He has been engaged by 20 international organizations and 13 national organizations, and helped them create entrepreneurial ecosystems to advance their community’s economic prosperity.
Dr. O’Neal currently serves on multiple international and local boards that advocate for research, commercialization, and entrepreneurism. These include the International Business Innovation Association (InBIA), the National Entrepreneur Center (NEC), Florida Business Incubation Association (FBIA), The Corridor (formerly the Florida High Tech Corridor Council), and FireSpring Fund, and the Florida Research Consortium, among many others.
Co-founder of Praxis Biotechnology, Inc., a research-driven pharmaceutical company that develops novel topical treatments for rosacea and other skin diseases.
Transonic Systems initiated out of Cornell University College of Veterinary Medicine with a novel ultrasound flowmeter technology which has since become the worldwide gold standard for a number of clinical diagnostic and animal studies applications
Richard Uhlig is the Founder and CEO of Quadrant Biosciences, a company which acquires, develops and commercializes innovative life-science technologies.
Karate students learn self-defense by repeating patterns of motion called “Kata.” Similarly, employees in your company can learn how to perform daily continuous improvement by practicing patterns of scientific thinking. Discover how to leverage the “Improvement Kata” and “Coaching Kata” patterns that are the foundations of Toyota’s world renowned continuous improvement culture. Real-world examples will illustrate how Kata generates results and ensures improvement activities are aligned with business goals.
Hod Lipson is a professor of Engineering and Data Science at Columbia University in New York, and a co-author of the award winning book “Fabricated: The New World of 3D printing”, and “Driverless: Intelligent cars and the road ahead”, by MIT Press (translated into 7 languages). Before joining Columbia University in 2015, Hod spent 14 years as a professor at Cornell University. He received his PhD in 1999 from the Technion – Israel Institute of Technology, followed by a postdoc at Brandeis University and MIT. Hod Lipson’s work on self-aware and self-replicating robots challenges conventional views of robotics, and has enjoyed widespread media coverage. He has also pioneered open-source 3D printing, as well as electronics 3D printing, bio-printing and food printing. Lipson has co-authored over 300 publications that received over 14,000 citations to date. He has co-founded four companies, and is frequent keynoter both in industry and academic events. His TED Talk on self-aware machines is one of the most viewed presentations on AI and robotics. Hod directs the Creative Machines Lab, which pioneers new ways to make machines that create, and machines that are creative.
A dynamic collaboration has advanced activities between the economic development organizations in Kingston, Ontario and Syracuse, NY to include research initiatives and innovation synergies between Queen’s University and Upstate Medical University, incorporating surrounding ecosystems and resources in both areas. This panel will discuss the history and objectives of the collaboration, current projects underway, economic development initiatives, and review of innovation assets, synergies and gaps.
Dr. Robert J. Corona is the John B Bernard Henry Professor of Pathology and Chair of Pathology and Laboratory Medicine at Upstate Medical University. He was recently appointed University Chief Innovation Officer and Associate Dean for Academic and Industry Relations. Dr. Corona is Clinical Chief of Pathology and Laboratory Medicine, Director of Neuropathology and President of Upstate Pathologists Laboratories, LLC.
Dr. Corona served as Vice President of Medical and Scientific Affairs and Chief Medical Officer at Welch Allyn, Inc. for 16 years. Prior to joining Welch Allyn, he was Physician Director of Medical Informatics, Laboratory Informatics and Telemedicine at SUNY Upstate Medical University. While at Upstate, he founded CareNet, a medical informatics and telemedicine program that won the Smithsonian Award for Innovation in Medicine.
Dr. Corona is board certified by the American Board of Pathology in Anatomic Pathology, Neuropathology and Clinical Informatics. He served on the New York State Board for Medicine for 10 years and the New York State Department of Health’s Board of Professional Medical Conduct. He remains an Emeritus Member of the New York State Board for Medicine.
After graduating from Ithaca College in 1982, Dr. Corona received his medical degree from NYCOM/ NYIT(now known as NYITCOM) in Long Island, New York. He did a general medical internship at Southeastern Medical Center in Miami, Florida, and his residency and fellowship at SUNY Upstate Medical University. He did an additional fellowship at the Armed Forces Institute of Pathology in Washington, DC. Dr. Corona also served as Chief Resident at SUNY Upstate Medical and as Co-Chairman of the Chief Resident's Association. Dr. Corona completed his MBA at University of Massachusetts at Amherst.
Andrew Bacchus works with Kingston from various sectors that are introducing a novel technology, or pursuing a growth strategy that requires some R&D collaboration with Queen’s University. Andrew is on the Board of SWITCH Ontario, and a community leader with Startup Kingston.
Kathi Durdon, MA, CCRP, Director of Operations, CNY Biotech Accelerator is responsible for development of collaborative initiatives and resource pathways to assist biotech innovators in the region.
David Hyndman is an Assistant Director, University Partnerships within the Office of Partnerships and Innovation at Queen’s University. In this role, he manages and coordinates research and development collaborations between Queen's University researchers and local and regional technology companies.
David Mankiewicz is a Senior Vice President for Research, Policy and Planning for CenterState CEO. He addresses issues involving economic development, center city revitalization, community improvement and comprehensive planning as well as serving as the President of the University Hill Corporation.
The connection of equipment, processes, and people within digitally empowered factories is happening now. Data analytics, the Internet of things, 3D printing, and other trending technologies are increasingly in use in large manufacturers. Learn more about Industry 4.0 and Smart Manufacturing technologies and how they can benefit small to midsize manufacturers.